Log in

NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

-1.42 (-3.59 %)
(As of 08/11/2020 04:00 PM ET)
Today's Range
Now: $38.16
50-Day Range
MA: $37.90
52-Week Range
Now: $38.16
Volume315,800 shs
Average Volume499,630 shs
Market Capitalization$1.92 billion
P/E Ratio12.76
Dividend YieldN/A
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More
Prestige Consumer Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.1Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.75 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products



Sales & Book Value

Annual Sales$963.01 million
Cash Flow$3.50 per share
Book Value$23.30 per share


Net Income$142.28 million


Market Cap$1.92 billion
Next Earnings Date10/29/2020 (Estimated)
-1.42 (-3.59 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

How has Prestige Consumer Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PBH shares have increased by 6.3% and is now trading at $38.16.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Prestige Consumer Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Prestige Consumer Healthcare

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Prestige Consumer Healthcare

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) posted its earnings results on Thursday, August, 6th. The company reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.70 by $0.16. The firm had revenue of $229.40 million for the quarter, compared to analyst estimates of $221.27 million. Prestige Consumer Healthcare had a net margin of 15.84% and a return on equity of 13.81%. The business's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period last year, the business posted $0.65 earnings per share.
View Prestige Consumer Healthcare's earnings history

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its second quarter earnings guidance on Thursday, August, 6th. The company provided earnings per share (EPS) guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus estimate of $0.71. The company issued revenue guidance of $225 million or more, compared to the consensus revenue estimate of $236.06 million.

What price target have analysts set for PBH?

7 Wall Street analysts have issued 1-year price objectives for Prestige Consumer Healthcare's stock. Their forecasts range from $43.00 to $97.00. On average, they expect Prestige Consumer Healthcare's stock price to reach $69.00 in the next twelve months. This suggests a possible upside of 80.8% from the stock's current price.
View analysts' price targets for Prestige Consumer Healthcare

Has Prestige Consumer Healthcare been receiving favorable news coverage?

Headlines about PBH stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a news impact score of 3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Prestige Consumer Healthcare

Are investors shorting Prestige Consumer Healthcare?

Prestige Consumer Healthcare saw a decline in short interest in February. As of February 15th, there was short interest totaling 7,970,000 shares, a decline of 15.0% from the January 31st total of 9,380,000 shares. Based on an average daily volume of 358,600 shares, the days-to-cover ratio is currently 22.2 days. Currently, 16.0% of the company's shares are short sold.
View Prestige Consumer Healthcare's Short Interest

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Wells Fargo & Co (WFC), IBM (IBM), Intel (INTC), Boeing (BA), Enterprise Products Partners (EPD) and Micron Technology (MU).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
  • Ms. Christine Sacco, Chief Financial Officer (Age 43)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
  • Mr. Jeff Zerillo, Sr. VP of Operations

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Macquarie Group Ltd. (3.54%), Fisher Asset Management LLC (1.58%), LSV Asset Management (1.43%), Jennison Associates LLC (1.06%), Palisade Capital Management LLC NJ (0.86%) and Russell Investments Group Ltd. (0.84%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors.
View institutional ownership trends for Prestige Consumer Healthcare

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., NN Investment Partners Holdings N.V., Dalton Greiner Hartman Maher & Co., Skyline Asset Management LP, Dupont Capital Management Corp, Fisher Asset Management LLC, Natixis Advisors L.P., and Cresset Asset Management LLC.
View insider buying and selling activity for Prestige Consumer Healthcare

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Macquarie Group Ltd., First Trust Advisors LP, Russell Investments Group Ltd., Mutual of America Capital Management LLC, Duality Advisers LP, Mackay Shields LLC, and Lapides Asset Management LLC.
View insider buying and selling activity for Prestige Consumer Healthcare

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $38.16.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $1.92 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.